| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director | Executive Chairman
5 companies
Hasnain Faheem serves as a President &CEO at GOSS and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 13 buys and 6 sells. Those positions are worth an estimated $1.9M at current prices.
Historically, Hasnain Faheem's trades have earned a strong insider score of 74/100 across 9 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +18.0%.
The biggest single holding is FBRX (~$1.1M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 143,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | KURA Kura Oncology, Inc. | Director | Sale+OE | 10,000 | $10.98 | $109,764.00 | -29.4% | -12.2% | - | |
| Mar 21, 2025 | KURA Kura Oncology, Inc. | Director | Sale+OE | 22,682 | $8.00 | $181,456.00 | -48.6% | -25.4% | +5.4% | |
| Jun 21, 2024 | GOSS Gossamer Bio, Inc. | President &CEO | Buy | 372,000 | $0.67 | $250,281.60 | +7.4% | +47.7% | +121.5% | |
| Mar 27, 2024 | GOSS Gossamer Bio, Inc. | President &CEO | Sell | 23,172 | $1.16 | $26,772.93 | -16.2% | -13.7% | -0.9% | |
| Mar 22, 2023 | GOSS Gossamer Bio, Inc. | President &CEO | Buy | 878,572 | $1.14 | $1,000,389.23 | +24.3% | +18.5% | +18.9% | |
| Jul 15, 2022 | GOSS Gossamer Bio, Inc. | President &CEO | Buy | 138,696 | $7.21 | $999,998.16 | +4.0% | +9.9% | -86.6% | |
| Mar 23, 2022 | GOSS Gossamer Bio, Inc. | President &CEO | Sell | 19,035 | $8.92 | $169,697.03 | -11.7% | -20.1% | -87.8% | |
| Oct 14, 2020 | GOSS Gossamer Bio, Inc. | Director | Buy | 96,520 | $10.36 | $999,995.46 | +2.9% | - | - | |
| Sep 27, 2019 | GOSS Gossamer Bio, Inc. | Director | Buy | 10,000 | $16.80 | $167,980.00 | +0.3% | - | - | |
| May 30, 2019 | FBRX Forte Biosciences, Inc. | Director | Buy | 43,000 | $4.66 | $200,314.52 | +21.2% | - | - |